Chemical activators of transmembrane 239 can initiate a cascade of intracellular events leading to its activation through various signaling pathways. Forskolin, for example, directly stimulates adenylate cyclase, which catalyzes the conversion of ATP to cAMP. The elevated cAMP levels in turn activate protein kinase A (PKA). Once activated, PKA can phosphorylate specific serine or threonine residues on transmembrane 239, thereby activating the protein. Similarly, IBMX works by inhibiting the degradation of cAMP by phosphodiesterases, maintaining an elevated intracellular concentration of cAMP, which sustains PKA activation and subsequent phosphorylation of transmembrane 239.
On another pathway, Epinephrine and Isoproterenol, both adrenergic receptor agonists, increase intracellular cAMP levels, further supporting the PKA-mediated phosphorylation of transmembrane 239. Cholera toxin also heightens cAMP levels by irreversibly activating adenylate cyclase, again leading to PKA activation. Dibutyryl-cAMP, a stable cAMP analog, bypasses the cell surface receptors and directly activates PKA, which phosphorylates transmembrane 239. In a different mechanism, PMA activates protein kinase C (PKC), which can phosphorylate transmembrane 239, although through a distinct set of phosphorylation sites compared to PKA. Ionomycin and A23187, calcium ionophores, raise intracellular calcium levels, activating calmodulin-dependent kinase (CaMK), which also has the potential to phosphorylate and activate transmembrane 239. Anisomycin, through its activation of JNK, indirectly promotes the activation of transcription factors like AP-1, which could upregulate the expression of kinases responsible for the phosphorylation of transmembrane 239. Okadaic acid prevents the dephosphorylation of proteins by inhibiting protein phosphatases, thus fostering a state where phosphorylation, including that of transmembrane 239, is maintained. Lastly, phosphatidic acid serves as a signaling lipid that can activate mTOR signaling pathways, leading to the phosphorylation of a variety of substrates, one of which can be transmembrane 239. Each of these chemicals, through their respective signaling pathways, ensures the activation of transmembrane 239 through phosphorylation, a key post-translational modification that regulates protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX (3-Isobutyl-1-methylxanthine) inhibits phosphodiesterases, preventing cAMP degradation, which supports the activation of PKA that could subsequently activate transmembrane 239 through phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA (Phorbol 12-myristate 13-acetate) activates protein kinase C (PKC), which may phosphorylate transmembrane 239, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK), potentially leading to the phosphorylation and activation of transmembrane 239. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, similarly activating CaMK, which in turn could phosphorylate and activate transmembrane 239. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can lead to an increase in intracellular cAMP levels, activating PKA, and potentially resulting in the phosphorylation and activation of transmembrane 239. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, enhances cAMP production, leading to the activation of PKA, which may phosphorylate and activate transmembrane 239. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can lead to the activation of AP-1 transcription factor, which may upregulate the expression of proteins that phosphorylate and activate transmembrane 239. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels in cells, which may include the phosphorylation and activation of transmembrane 239. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Phosphatidic acid can serve as a signal transducer that activates mTOR signaling, which may result in the phosphorylation and activation of downstream proteins including transmembrane 239. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, directly activates PKA, which could lead to the phosphorylation and functional activation of transmembrane 239. | ||||||